Antipentylenetetrazol action of clobazam in developing rats
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
10783916
Knihovny.cz E-zdroje
- MeSH
- antikonvulziva farmakologie MeSH
- anxiolytika farmakologie MeSH
- benzodiazepiny * MeSH
- epilepsie generalizovaná chemicky indukované farmakoterapie MeSH
- klobazam MeSH
- konvulziva MeSH
- krysa rodu Rattus MeSH
- mozek růst a vývoj patofyziologie MeSH
- pentylentetrazol MeSH
- potkani Wistar MeSH
- věkové faktory MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- záchvaty chemicky indukované farmakoterapie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antikonvulziva MeSH
- anxiolytika MeSH
- benzodiazepiny * MeSH
- klobazam MeSH
- konvulziva MeSH
- pentylentetrazol MeSH
Clobazam (0.5 to 7.5 mg/kg i.p.) was tested against motor seizures elicited by pentylenetetrazol in rats 7, 12, 18, 25 and 90 days old. Minimal, predominantly clonic seizures with preserved righting ability were reliably induced by pentylenetetrazol and suppressed by clobazam in rats aged 18 days or more. The incidence of minimal seizures after clobazam pretreatment was not increased in 7- and 12-day-old rat pups. Generalized tonic-clonic seizures were markedly suppressed by clobazam in all age groups. In 18-day-old and older animals clobazam doses suppressing generalized seizures were always lower than those necessary for exerting an effect on minimal seizures. The differences in clobazam action appearing at various levels of maturation are only quantitative.
Epilepsy Research in the Institute of Physiology of the Czech Academy of Sciences in Prague